La mediación como recurso pedagógico por y para la convivencia pacífica en los centros educativos

Resumen: Los centros educativos son un lugar de convivencia y, como en otros ámbitos de la sociedad, se producen conflictos. Si no se gestionan de manera positiva, éstos pueden afectar a dicha convivencia y para ello, se deben fomentar habilidades sociales específicas como lo es la mediación. Como estructura sistémica, la mediación es una herramienta de trabajo por y para la convivencia pacífica en los centros, en la que los alumnos adquieren un papel protagonista en su propia educación. Así, a través del diálogo los alumnos afrontan los problemas que surgen diariamente, adquiriendo compromisos y responsabilidades, tanto consigo mismo como con los demás; lo que mejora sensiblemente el clima escolar.

Joko Sortzailea haur hezkuntzan: DBH-ko Marrazketa Teknikoko ikasleek, prozesu sortzailearen bidez sortutako Haur Hezkuntzarako jokoa

[eus] Lan honen ikerkuntza gaia sormena da. Ibilbide honetan, sormena ardatz eta oinarri hartuz, DBH-ko Marrazketa Teknikoko ikasleek Haur Hezkuntzako umeentzat bideratutako Formak jokoa asmatu dute. Bi erronka nagusi izan ditu lan honek: alde batetik, DBH-ko ikasleekin batera, aholkulari lanak eginez, jokoa eraikitzeko prozesu sortzaile bat aurrera eramatea. Bestetik, HH-ko umeentzat joko sortzaile bat formulatzea. Joko honen helburu nagusiena pertsona guztiengan existitzen den sormen gaitasuna bultzatzea, sustatzea eta garatzea izan delarik. Bidean azaldu diren erronkei aurre egin eta konponbidea topatzerako orduan, egilearen Haur zein Bigarren hezkuntzako hezitzaile perfil bikoitza ezinbesteko tresna izan da. Ikuspuntu bikoitz honek, sormenaren txertatzea hezkuntzako fase bakoitzari egokitzea ahalbidetu du, hezkuntza prozesu globala dela argi izanik.

A Delphi Process to Optimize Quality and Performance of Drug Evaluation in Neonates

Background: Neonatal trials remain difficult to conduct for several reasons: in particular the need for study sites to have an existing infrastructure in place, with trained investigators and validated quality procedures to ensure good clinical, laboratory practices and a respect for high ethical standards. The objective of this work was to identify the major criteria considered necessary for selecting neonatal intensive care units that are able to perform drug evaluations competently. Methodology and Main Findings: This Delphi process was conducted with an international multidisciplinary panel of 25 experts from 13 countries, selected to be part of two committees (a scientific committee and an expert committee), in order to validate criteria required to perform drug evaluation in neonates. Eighty six items were initially selected and classified under 7 headings: "NICUs description - Level of care'' (21), "Ability to perform drug trials: NICU organization and processes (15), "Research Experience'' (12), "Scientific competencies and area of expertise'' (8), "Quality Management'' (16), "Training and educational capacity'' (8) and "Public involvement'' (6). Sixty-one items were retained and headings were rearranged after the first round, 34 were selected after the second round. A third round was required to validate 13 additional items. The final set includes 47 items divided under 5 headings. Conclusion: A set of 47 relevant criteria will help to NICUs that want to implement, conduct or participate in drug trials within a neonatal network identify important issues to be aware of. Summary Points: 1) Neonatal trials remain difficult to conduct for several reasons: in particular the need for study sites to have an existing infrastructure in place, with trained investigators and validated quality procedures to ensure good clinical, laboratory practices and a respect for high ethical standards. 2) The present Delphi study was conducted with an international multidisciplinary panel of 25 experts from 13 countries and aims to identify the major criteria considered necessary for selecting neonatal intensive care units (NICUs) that are able to perform drug evaluations competently. 3) Of the 86 items initially selected and classified under 7 headings - "NICUs description - Level of care'' (21), "Ability to perform drug trials: NICU organization and processes (15), "Research Experience'' (12), "Scientific competencies and area of expertise'' (8), "Quality Management'' (16), "Training and educational capacity'' (8) and "Public involvement'' (6) - 47 items were selected following a three rounds Delphi process. 4) The present consensus will help NICUs to implement, conduct or participate in drug trials within a neonatal network.